{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:23:00Z","timestamp":1785277380387,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ejogrb.2015.09.024","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T21:53:42Z","timestamp":1444168422000},"page":"72-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"special_numbering":"C","title":["Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS"],"prefix":"10.1016","volume":"195","author":[{"given":"Fabio","family":"Facchinetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Bizzarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"D\u2019Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lanzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Soulage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Carlo","family":"Di Renzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Hod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony T.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdravko A.","family":"Kamenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Carlomagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Montanino","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Devroey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2015.09.024_bib0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.OGX.0000109523.25076.E2","article-title":"Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls","volume":"59","author":"Legro","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0225","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","article-title":"Molecular mechanisms of insulin resistance in polycystic ovary syndrome","volume":"12","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0230","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","author":"Moran","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0235","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1590\/0004-2730000003051","article-title":"Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances","volume":"58","author":"Spritzer","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/humupd\/dmn043","article-title":"Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis","volume":"15","author":"Nieuwenhuis-Ruifrok","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0245","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.metabol.2008.02.011","article-title":"An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet","volume":"57","author":"Glueck","year":"2008","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0250","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/2042018812437355","article-title":"The effects of old, new and emerging medicines on metabolic aberrations in PCOS","volume":"3","author":"Bargiota","year":"2012","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0255","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.fertnstert.2010.12.002","article-title":"The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study","volume":"95","author":"Ladson","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0260","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/dem005","article-title":"Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review","volume":"22","author":"Costello","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0265","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/humrep\/den097","article-title":"Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism","volume":"23","author":"Baillargeon","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0270","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2337\/diacare.29.02.06.dc05-1070","article-title":"Altered d-chiro-inositol urinary clearance in women with polycystic ovary syndrome","volume":"29","author":"Baillargeon","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0275","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1210\/en.2010-1353","article-title":"The adapter protein APPL1 links FSH receptor to inositol 1,4,5-trisphosphate production and is implicated in intracellular Ca(2+) mobilization","volume":"152","author":"Thomas","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0280","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2007-0366","article-title":"A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates\/Ca2+ cascade mediates TSH action on thyroid hormone synthesis","volume":"92","author":"Grasberger","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0285","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1507\/endocrj.EJ13-0423","article-title":"Decreased myo-inositol to chiro-inositol (M\/C) ratios and increased M\/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls","volume":"61","author":"Heimark","year":"2014","journal-title":"Endocr J"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0290","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/humrep\/deg113","article-title":"Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes","volume":"18","author":"Chiu","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0295","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/humrep\/17.6.1591","article-title":"Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality","volume":"17","author":"Chiu","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0300","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10815-014-0188-1","article-title":"Improvement of mouse embryo quality by myo-inositol supplementation of IVF media","volume":"31","author":"Colazingari","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0305","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejogrb.2009.09.008","article-title":"Contribution of myo-inositol to reproduction","volume":"147","author":"Papaleo","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"June","key":"10.1016\/j.ejogrb.2015.09.024_bib0310","first-page":"1","article-title":"Results from the International Consensus Conference on myo-inositol and d-chiro-inositol in Obstetrics and Gynecology \u2013 assisted reproduction technology","author":"Bevilacqua","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0315","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/13697137.2011.631063","article-title":"One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome","volume":"15","author":"Santamaria","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0320","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/gme.0b013e3181e8e1b1","article-title":"Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study","volume":"18","author":"Giordano","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0325","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/1933719113518985","article-title":"Hyperinsulinemia alters myoinositol to d-chiroinositol ratio in the follicular fluid of patients with PCOS","volume":"21","author":"Unfer","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0330","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0335","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.fertnstert.2011.05.027","article-title":"The d-chiro-inositol paradox in the ovary","volume":"95","author":"Carlomagno","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0340","first-page":"452","article-title":"Myo-inositol rather than d-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial","volume":"15","author":"Unfer","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0345","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.mehy.2012.01.009","article-title":"Oocyte quality reflected by follicular fluid analysis in polycystic ovary syndrome (PCOS): a hypothesis based on intermediates of energy metabolism","volume":"78","author":"Arya","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0350","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/09513590.2011.650660","article-title":"Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials","volume":"28","author":"Unfer","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0355","first-page":"575","article-title":"The combined therapy with myo-inositol and d-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone","volume":"16","author":"Nordio","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0360","first-page":"537","article-title":"The combined therapy myo-inositol plus d-chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients","volume":"17","author":"Minozzi","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0365","first-page":"105","article-title":"Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial","volume":"13","author":"Costantino","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0370","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/09513590801893232","article-title":"Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome","volume":"24","author":"Genazzani","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0375","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/09513590701672405","article-title":"Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction","volume":"23","author":"Papaleo","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0380","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","article-title":"Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome","volume":"340","author":"Nestler","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0385","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.metabol.2008.05.008","article-title":"Insulin-stimulated release of d-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome","volume":"57","author":"Cheang","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0390","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1517\/17425247.2012.701616","article-title":"Myo-inositol soft gel capsules may prevent the risk of coffee-induced neural tube defects","volume":"9","author":"De Grazia","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0395","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1136\/jmg.39.2.e5","article-title":"Inositol and folate resistant neural tube defects","volume":"39","author":"Cavalli","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0400","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/bdra.20454","article-title":"Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs","volume":"82","author":"Cavalli","year":"2008","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0405","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/bdra.22853","article-title":"Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy","volume":"91","author":"Cavalli","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0410","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/09513590.2011.633665","article-title":"Myo-inositol may prevent gestational diabetes in PCOS women","volume":"28","author":"D\u2019Anna","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0415","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1464-5491.2011.03284.x","article-title":"The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes","volume":"28","author":"Corrado","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0420","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2337\/dc12-1371","article-title":"myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study","volume":"36","author":"D\u2019Anna","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejogrb.2015.09.024_bib0425","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/14767058.2013.766691","article-title":"Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial","volume":"26","author":"Matarrelli","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"Suppl.","key":"10.1016\/j.ejogrb.2015.09.024_bib0430","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ajog.2012.10.234","article-title":"Myo-inositol supplementation in pregnancies at risk for gestational diabetes. Interim analysis of a randomized controlled trial (RCT)","volume":"208","author":"Facchinetti","year":"2013","journal-title":"Am J Obstet Gynecol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211515003292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211515003292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:35:32Z","timestamp":1759556132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211515003292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":43,"alternative-id":["S0301211515003292"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2015.09.024","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2015.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}